Greenlight Capital’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $101K | Hold |
|
|||||
|
2023
Q3 | $119K | Hold |
|
|||||
|
2023
Q2 | $255K | Sell |
|
|||||
|
2023
Q1 | $505K | Hold |
|
|||||
|
2022
Q4 | $519K | Hold |
|
|||||
|
2022
Q3 | $1.08M | Hold |
|
|||||
|
2022
Q2 | $2.86M | Hold |
|
|||||
|
2022
Q1 | $5.13M | Hold |
|
|||||
|
2021
Q4 | $7.66M | Hold |
|
|||||
|
2021
Q3 | $9.84M | Hold |
|
|||||
|
2021
Q2 | $13.1M | Buy |
|
|||||
|
2021
Q1 | $15M | Hold |
|
|||||
|
2020
Q4 | $14.2M | Hold |
|
|||||
|
2020
Q3 | $15.4M | Buy |
|
|||||
|
2020
Q2 | $16.7M | Buy |
|
|||||
|
2020
Q1 | $11M | Hold |
|
|||||
|
2019
Q4 | $11.1M | Hold |
|
|||||
|
2019
Q3 | $7.68M | Buy |
|